Cleared Special

QUANTITATIVE ANALYSIS OF LEFT VENTRICULAR ANGIOGRAMS (QLV) (K993765) - FDA 510(k) Clearance

Class II Radiology device cleared through the Special 510(k) pathway - typically does not require clinical trials.

K993765 · Medis Medical Imaging Systems BV · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 1999
Decision
18d
Days
Class 2
Risk

K993765 is an FDA 510(k) clearance for the QUANTITATIVE ANALYSIS OF LEFT VENTRICULAR ANGIOGRAMS (QLV). Classified as System, X-ray, Angiographic (product code IZI), Class II - Special Controls.

Submitted by Medis Medical Imaging Systems BV (Ridgefield, US). The FDA issued a Cleared decision on November 26, 1999 after a review of 18 days - a notably fast clearance cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.1600 - the FDA radiology and imaging software oversight framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Medis Medical Imaging Systems BV devices

Submission Details

510(k) Number K993765 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 08, 1999
Decision Date November 26, 1999
Days to Decision 18 days
Submission Type Special
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
89d faster than avg
Panel avg: 107d · This submission: 18d
Pathway characteristics
Modification to existing cleared device.

Device Classification

Product Code IZI System, X-ray, Angiographic
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.1600
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - IZI System, X-ray, Angiographic

All 198
Devices cleared under the same product code (IZI) and FDA review panel - the closest regulatory comparables to K993765.
780 nm SPY Portable Handheld Imaging (SPY-PHI) System
K261037 · Stryker Endoscopy · May 2026
SURGIMAGE SIM 1000H Fluorescence Imaging Platform
K253181 · Surgimage Corporation · May 2026
IC-Flow™ Imaging System 2.0
K243645 · Diagnostic Green GmbH · Sep 2025
Affirm 800
K243077 · Digital Surgery Systems, Inc. (D.B.A True Digital Surgery) · Jun 2025
Modus IR
K231986 · Synaptive Medical, Inc. · Mar 2024
EXPLORER AIR® II (8001, 8002, 8003)
K234090 · Surgvision GmbH · Mar 2024